FIRST LIGHT ASSET MANAGEMENT LLC
Q3 2024 Form 13-F
EDINA, MINNESOTA
CIK 0001600004
· CRD 168899
· SEC-registered investment adviser
$1.2B Reported Value Total
FIRST LIGHT ASSET MANAGEMENT, LLC reports 1,165 total accounts under management (AUM). There are 1,165 discretionary accounts valued at $1,387,863,426, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
4 funds
· $1.1B gross asset value
Hedge Fund: $1.1B
Source: Form ADV filed 2026-03-24
Reported value
$1.2B
Quarter over quarter
+14.5%
Holdings
38
Top-10 concentration
47.7%
Filing Structure
Key People
Form ADV owners & control persons
Mathew Paul Arens
MANAGING MEMBER, CEO, & SENIOR PORTFOLIO MANAGER
Brett Thomas Johnson
SENIOR RESEARCH ANALYST & FOUNDING PRINCIPAL
Kurt Terry Peterson
CHIEF FINANCIAL OFFICER & CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2024 13F record
Q3 2024 13F filing summary
| Period of report | September 30, 2024 |
|---|---|
| Filed | November 14, 2024 |
| Form | 13F-HR |
| Reported value | $1.2B |
| Positions | 38 |
| Change in reported value | +5.4% |
| New positions | 5 |
| Exited positions | 11 |
| Position turnover | 32.7% |
| Top-10 concentration | 47.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
32 | $1.7B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
31 | $1.6B |
|
Q1 2026 13F
Filed May 15, 2026
|
35 | $1.1B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
33 | $1.3B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
41 | $1.1B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
38 | $771.3M |
|
Q1 2025 13F
Filed May 15, 2025
|
37 | $875.7M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
36 | $1.0B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
38 | $1.2B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
44 | $1.1B |
|
Q1 2024 13F
Filed May 15, 2024
|
50 | $1.3B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
75 | $1.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
75 | $1.1B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
79 | $1.3B |
|
Q1 2023 13F
Filed May 15, 2023
|
74 | $1.1B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
74 | $1.1B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
71 | $988.1M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
71 | $859.4M |
|
Q1 2022 13F
Filed May 13, 2022
|
75 | $1.1B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
79 | $1.4B |
32 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | CNTA CENTESSA PHARMACEUTICALS LIMITED | $95.0M | 7.9% |
| 2 | FNA PARAGON 28 INC | $67.8M | 5.64% |
| 3 | EVH EVOLENT HEALTH INC | $65.0M | 5.41% |
| 4 | AXGN AXOGEN INC | $57.3M | 4.77% |
| 5 | ATRC ATRICURE INC | $52.3M | 4.35% |
| 6 | INSM INSMED INC | $50.3M | 4.18% |
| 7 | CRNX CRINETICS PHARMACEUTICALS INC | $48.2M | 4.01% |
| 8 | XENE XENON PHARMACEUTICALS | $46.5M | 3.87% |
| 9 | NEO NEOGENOMICS INC | $45.4M | 3.78% |
| 10 | DYN DYNE THERAPEUTICS INC | $45.2M | 3.76% |
| 11 | TNDM TANDEM DIABETES CARE INC | $43.5M | 3.62% |
| 12 | RARE ULTRAGENYX PHARMACEUTICAL INC | $41.9M | 3.49% |
| 13 | PFMT PERFORMANT FINANCIAL CORPORATION | $41.9M | 3.49% |
| 14 | TMDX TRANSMEDICS GROUP INC | $41.7M | 3.47% |
| 15 | OSCR OSCAR HEALTH INC CLASS A | $37.5M | 3.12% |
| 16 | PODD INSULET CORP | $37.0M | 3.08% |
| 17 | HCAT HEALTH CATALYST INC | $35.0M | 2.91% |
| 18 | ANAB ANAPTYS BIO INC | $31.8M | 2.64% |
| 19 | CDMO AVID BIOSERVICES INC | $31.5M | 2.62% |
| 20 | VERA VERA THERAPEUTICS INC | $31.2M | 2.59% |
Values as reported on the Q3 2024 Form 13F. Every position is in the holdings table below.